High materiality7/10
Axsome Therapeutics price target lowered to $247 from $251 at Morgan Stanley
Why it may matterVerify against the original reporting
PT still above current price; upside remains.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley lowers AXSM PT to $247; current price $198.57; price down 0.5% since signal.
- Morgan Stanley lowers AXSM PT to $247; price $198.57.
Key facts
- 01
Target: $247
- 02
Posted price: $198.57
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.